Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osamu Ando

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Antibiotics|June 23, 2016
Ogipeptins, novel inhibitors of LPS: physicochemical properties and structural elucidationYuki Hirota-Takahata, Shiho Kozuma, Nahoki Kuraya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infectionTsu-Fan Cheng, Sabrina Brzostek, Osamu Ando, et al.
The Journal of Biological Chemistry|July 8, 2011
Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 productionSaori Fujita-Sato, Shuichiro Ito, Takashi Isobe, et al.
The Journal of Antibiotics|March 10, 2016
Studies on novel HIF activators, A-503451s.I. Producing organism, fermentation, isolation and structural elucidationYuki Hirota-Takahata, Hideki Kobayashi, Masaaki Kizuka, et al.
Pharmaceutical Research|May 12, 2018
Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy VolunteersIssey Takehara, Takashi Yoshikado, Keiko Ishigame, et al.
Pharmaceutical Research|February 22, 2019
Correction to: Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy VolunteersIssey Takehara, Takashi Yoshikado, Keiko Ishigame, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2004
Cotreatment with interferon-alpha and -gamma reduces liver fibrosis in a rat modelTerumi Takahara, Kota Sugiyama, Li Ping Zhang, et al.
Pharmaceutical Research|May 28, 2017
Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese VolunteersIssey Takehara, Hanano Terashima, Takeshi Nakayama, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 21, 2018
In vivo multiple metabolic pathways for a novel G protein-coupled receptor 119 agonist DS-8500a in rats: involvement of the 1,2,4-oxadiazole ring-opening reductive reaction in livers under anaerobic conditionsChie Makino, Akiko Watanabe, Tsuneo Deguchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 13, 2019
Elucidation of <i>N</i> <sup>1</sup>-methyladenosine as a Potential Surrogate Biomarker for Drug Interaction Studies Involving Renal Organic Cation TransportersTakeshi Miyake, Tadahaya Mizuno, Issey Takehara, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Antibiotics|June 23, 2016
Ogipeptins, novel inhibitors of LPS: physicochemical properties and structural elucidationYuki Hirota-Takahata, Shiho Kozuma, Nahoki Kuraya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infectionTsu-Fan Cheng, Sabrina Brzostek, Osamu Ando, et al.
The Journal of Biological Chemistry|July 8, 2011
Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 productionSaori Fujita-Sato, Shuichiro Ito, Takashi Isobe, et al.
The Journal of Antibiotics|March 10, 2016
Studies on novel HIF activators, A-503451s.I. Producing organism, fermentation, isolation and structural elucidationYuki Hirota-Takahata, Hideki Kobayashi, Masaaki Kizuka, et al.
Pharmaceutical Research|May 12, 2018
Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy VolunteersIssey Takehara, Takashi Yoshikado, Keiko Ishigame, et al.
Pharmaceutical Research|February 22, 2019
Correction to: Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy VolunteersIssey Takehara, Takashi Yoshikado, Keiko Ishigame, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 24, 2004
Cotreatment with interferon-alpha and -gamma reduces liver fibrosis in a rat modelTerumi Takahara, Kota Sugiyama, Li Ping Zhang, et al.
Pharmaceutical Research|May 28, 2017
Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese VolunteersIssey Takehara, Hanano Terashima, Takeshi Nakayama, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 21, 2018
In vivo multiple metabolic pathways for a novel G protein-coupled receptor 119 agonist DS-8500a in rats: involvement of the 1,2,4-oxadiazole ring-opening reductive reaction in livers under anaerobic conditionsChie Makino, Akiko Watanabe, Tsuneo Deguchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 13, 2019
Elucidation of <i>N</i> <sup>1</sup>-methyladenosine as a Potential Surrogate Biomarker for Drug Interaction Studies Involving Renal Organic Cation TransportersTakeshi Miyake, Tadahaya Mizuno, Issey Takehara, et al.
Pageof 4